Pancreatic Cancer: Advances in Science and Clinical Care

​Sept. 6-9, 2019
Westin Copley Place
Boston, Massachusetts

Conference Cochairs
Dafna Bar-Sagi, New York University Langone Medical Center, New York, New York
Luis A. Diaz, Memorial Sloan Kettering Cancer Center, New York, New York
Elizabeth M. Jaffee, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Ben Z. Stanger, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
Brian M. Wolpin, Dana-Farber Cancer Institute, Boston, Massachusetts

  • View Program
  • Watch this message from Conference Cochair Ben Z. Stanger

This will be the sixth AACR Special Conference on pancreatic cancer. According to the U.S. National Cancer Institute, pancreatic cancer will account for approximately 44,330 deaths in 2018 and is poised to become the third leading cause of cancer deaths by 2030. As the field continues to grow, it is imperative that researchers can interact, share data, and discuss ideas to help reach the overall goal of improved treatment for pancreatic cancer. This conference will showcase sessions on tumor heterogeneity, immunology, prevention and early detection, and novel treatment combinations, among others. With continued support from the Lustgarten Foundation and the Pancreatic Cancer Action Network, we anticipate that many of the leading researchers and clinicians in pancreatic cancer research will participate in the program.

Lead Supporters



Professional Educational Grants





Funding for this conference was made possible (in part) by 1R13CA243264-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

CME-MOC_badge_170x.jpgContinuing Medical Education Activity AMA PRA Category 1 CreditsTM available